Glowinska, I.; Labij-Reduta, B.; Juzwiuk, J.; Lukaszewicz, M.; Pietruczuk, A.; Poplawska, A.; Daniluk-Jamro, A.; Kakareko, K.; Rydzewska-Rosolowska, A.; Naumnik, B.;
et al. Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy. J. Clin. Med. 2022, 11, 4984.
https://doi.org/10.3390/jcm11174984
AMA Style
Glowinska I, Labij-Reduta B, Juzwiuk J, Lukaszewicz M, Pietruczuk A, Poplawska A, Daniluk-Jamro A, Kakareko K, Rydzewska-Rosolowska A, Naumnik B,
et al. Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy. Journal of Clinical Medicine. 2022; 11(17):4984.
https://doi.org/10.3390/jcm11174984
Chicago/Turabian Style
Glowinska, Irena, Barbara Labij-Reduta, Jerzy Juzwiuk, Magdalena Lukaszewicz, Adam Pietruczuk, Agata Poplawska, Anna Daniluk-Jamro, Katarzyna Kakareko, Alicja Rydzewska-Rosolowska, Beata Naumnik,
and et al. 2022. "Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy" Journal of Clinical Medicine 11, no. 17: 4984.
https://doi.org/10.3390/jcm11174984
APA Style
Glowinska, I., Labij-Reduta, B., Juzwiuk, J., Lukaszewicz, M., Pietruczuk, A., Poplawska, A., Daniluk-Jamro, A., Kakareko, K., Rydzewska-Rosolowska, A., Naumnik, B., Koc-Zorawska, E., Zorawski, M., & Hryszko, T.
(2022). Factors Influencing Longevity of Humoral Response to SARS-CoV-2 Vaccination in Patients with End Stage Kidney Disease Receiving Renal Replacement Therapy. Journal of Clinical Medicine, 11(17), 4984.
https://doi.org/10.3390/jcm11174984
